Specifically in the lung, inhibition of bradykinin metabolic breakdown by ACE inhibitors or exogenous administration of B2 receptor agonists exerted protective effects, reducing pulmonary arterial pressure in experimental hypertension [50] and neutrophil recruitment by lipopolysaccharide [4]. Here, KNG1 is linked to hypertensive disorder.